Therapeutic equivalence [Design Issues]

posted by raghu – India, 2011-02-09 11:07 (5611 d 15:30 ago) – Posting: # 6600
Views: 9,098

Dear Mr Kishore,

You can conduct BE study in healthy volunteers if the anticancer drug not shows any cytotoxic or any major health risk for participating healthy subjects.

Therapeutic equivalence study should be conducted in patients.

Regards
Raghu.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
143 visitors (0 registered, 143 guests [including 23 identified bots]).
Forum time: 03:37 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5